Most of my colleagues wait till their patients are maxed out on oral medications — often this means that they are on 3 or 4 medications without achieving control, before starting them on either basal insulin or GLP-1 analogs….
Read More »A Pharmacist’s Perspective: Stuart T. Haines, PharmD, FCCP, FASHP, FAPhA
Patient Education and Monitoring Recommendations for the Use of GLP-1’s Unlike most diseases, diabetes requires extensive patient self-management….
Read More »GLP-1 and Appetite Suppression
There has been an increased use of GLP-1 analogs in patients with diabetes over the past two years as the advent of daily dosing has made medication adherence simpler and more clinicians are comfortable with the available choices.
Read More »Fall Much? You Need to Exercise More, Not Less, to Prevent Falls
By Sheri R. Colberg, PhD Just the other day I heard someone who was kidding around facetiously say to his colleague, "Help, I’ve fallen and I can’t get up!" That phrase is actually a registered trademark of Life Alert Emergency Response and commonly joked about, but it’s no …
Read More »Simply Suppressing Hedonism or Truly a Magic Bullet for Obesity?
Aaron I. Vinik, MD, PhD, FCP, MACP Eastern Virginia Medical School, Strelitz Diabetes and Neuroendocrine Center Department of Medicine, Division of Endocrinology and Metabolism Norfolk, Virginia USA Topiramate is a structurally novel anti-epileptic drug effective in management of various types of epilepsy and prevention of migraine headaches. A sulfamate substituted …
Read More »Heart Disease and Diabetes Guide
From dLife comes a guide (in pdf format) that can help your patients better understand how diabetes can cause cardiovascular disease. Can your patients answer the question: What percent of patients with diabetes are affected by cardiovascular complications?
Read More »Doing So Little Exercise Can Have Such a Big Effect
By Sheri R. Colberg, PhD For those of us who are reasonably fit and exercise regularly, it is hard for us to imagine that people who are currently sedentary, unfit, or overweight can benefit metabolically from doing something like simply taking breaks from sitting. However, the research in this …
Read More »GLP-1 Analogs and DeFronzo’s Octet
For over two decades, GLP-1 has been heavily investigated as the most promising therapy target in type 2 diabetes patients….
Read More »What You Can Do to Stop the Blood Sugar Rollercoaster
If you find that your blood sugars often fluctuate from too high to too low (and vice versa), you’re on the blood sugar rollercoaster. To learn how to eliminate the extremes, you’ll have to do a little sleuthing on your own. Get out your blood glucose meter, and for a …
Read More »SPECIAL FEATURE: Readers Respond to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources”
For Dr. Kahn’s comments and the Joslin Diabetes Center’s response, see our article in last week’s newsletter: Joslin Replies to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources.”
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.